FDA Demands Swift Improvement After “Unacceptable” Pension Management Performance

The FDA is calling for immediate improvements in pension management due to unacceptable performance from the administrator, Capita. Members who are retiring or nearing retirement are often left without vital information regarding their pensions, such as payment schedules.
Pension Management Concerns
Adrian Prandle, the FDA Assistant General Secretary, highlighted these issues in a statement to Civil Service World. He emphasized that the lack of clarity surrounding pension payments hampers members’ abilities to make informed retirement decisions.
Unacceptable Delays
Prandle stated, “This is unacceptable. Our members cannot expect to put their lives on hold any longer.” The consequences of this inadequate service are significant, impacting members’ plans and daily lives.
Efforts for Improvement
In response to these concerns, the FDA has been actively engaging with the Cabinet Office. The union is pressing for Capita to enhance its services. They recently arranged for Capita representatives to attend discussions to address the impact of their poor service on members’ retirement plans.
Ongoing Communication
The FDA maintains regular contact with the Cabinet Office, emphasizing the urgency of the situation. They have established an escalation route to address cases with immediate financial implications, though this system is currently overwhelmed with high case volumes.
- Frequency of retirement-related issues reported by members.
- Push for faster and more accurate services from Capita.
- Collaboration with departments and other trade unions on improving pension services.
Contact Information
Current or associate FDA members facing difficulties with their pensions are encouraged to reach out to the union. For assistance, they can contact the FDA directly at [email protected].




